Vecten, M.; Pion, E.; Bartoli, M.; Morales, R.J.; Sternberg, D.; Rendu, J.; Stojkovic, T.; Bourdain, C.A.; Métay, C.; Richard, I.;
et al. Objective Evaluation of Clinical Actionability for Genes Involved in Myopathies: 63 Genes with a Medical Value for Patient Care. Int. J. Mol. Sci. 2022, 23, 8506.
https://doi.org/10.3390/ijms23158506
AMA Style
Vecten M, Pion E, Bartoli M, Morales RJ, Sternberg D, Rendu J, Stojkovic T, Bourdain CA, Métay C, Richard I,
et al. Objective Evaluation of Clinical Actionability for Genes Involved in Myopathies: 63 Genes with a Medical Value for Patient Care. International Journal of Molecular Sciences. 2022; 23(15):8506.
https://doi.org/10.3390/ijms23158506
Chicago/Turabian Style
Vecten, Maude, Emmanuelle Pion, Marc Bartoli, Raul Juntas Morales, Damien Sternberg, John Rendu, Tanya Stojkovic, Cécile Acquaviva Bourdain, Corinne Métay, Isabelle Richard,
and et al. 2022. "Objective Evaluation of Clinical Actionability for Genes Involved in Myopathies: 63 Genes with a Medical Value for Patient Care" International Journal of Molecular Sciences 23, no. 15: 8506.
https://doi.org/10.3390/ijms23158506
APA Style
Vecten, M., Pion, E., Bartoli, M., Morales, R. J., Sternberg, D., Rendu, J., Stojkovic, T., Bourdain, C. A., Métay, C., Richard, I., Cerino, M., Milh, M., Campana-Salort, E., Gorokhova, S., Levy, N., Latypova, X., Bonne, G., Biancalana, V., Petit, F.,
... Cossée, M.
(2022). Objective Evaluation of Clinical Actionability for Genes Involved in Myopathies: 63 Genes with a Medical Value for Patient Care. International Journal of Molecular Sciences, 23(15), 8506.
https://doi.org/10.3390/ijms23158506